PCV53 ALISKIREN COMBINED WITH ANGIOTENSIN II-RECEPTOR BLOCKERS (ARB) RESULTED IN BETTER OUTCOMES COMPARED TO ARB COMBINED WITH ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACEI)- RESULTS FROM A CLAIMS DATABASE ANALYSIS
Abstract
Authors
JR Chang W Yang KH Kahler TS Fellers J Orloff AG Bensimon AP Yu Fan CPS EQ Wu